The Early Awareness and Alert System in Sweden: History and Current Status

Frontiers in Pharmacology

Volumn 8, Issue OCT, 2017, Pages

  Eriksson, Irene ^a,b   Wettermark, Björn ^a,b   Persson, Marie ^a   Edström, Morgan ^c   Godman, Brian ^d,e,f   Lindhé, Anna ^g   Malmström, Rickard E ^b,e   Ramström, Helena ^a   von Euler, Mia ^b,e,h   Christensen, Anna Bergkvist ⁱ  

^a STOCKHOLM COUNTY COUNCIL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF LIVERPOOL MANAGEMENT SCHOOL   (United Kingdom)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^g Research and Development Center Fyrbodal   (Sweden)

^h STOCKHOLM SÖDER HOSPITAL   (Sweden)

ⁱ Regional Head Office Region Skåne ^*  (Sweden)

Author keywords

Early awareness and alert systems; Health policy; Health technology assessment; Horizon scanning; Innovation; Sweden

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; DATA BASE; DECISION MAKING; EARLY AWARENESS AND ALERT SYSTEM; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; INFORMATION DISSEMINATION; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; REVIEW; SWEDEN;

EID: 85030626951     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00674     Document Type: Review

References (34)

1. AHRQ (2017). AHRQ Healthcare Horizon Scanning System. The Agency for Healthcare Research and Quality. Available online at: http://effectivehealthcare.ahrq.gov/index.cfm/who-is-involved-in-the-effective-health-care-program1/ahrq-horizon-scanning-system/ (Accessed June 1, 2017).
2. Anell, A., Glenngård, A. H., and Merkur, S. M. (2012). Sweden: health system review. Health Syst. Transit. 14, 1-159. Available online at: http://www.euro.who.int/__data/assets/pdf_file/0008/164096/e96455.pdf.
3. Anell, A. (2015). The public-private pendulum-patient choice and equity in sweden. N. Engl. J. Med. 372, 1-4. doi: 10.1056/NEJMp1411430.
4. Campbell, S. M., Godman, B., Diogene, E., Furst, J., Gustafsson, L. L., MacBride-Stewart, S., et al. (2015). Quality indicators as a tool in improving the introduction of new medicines. Basic Clin. Pharmacol. Toxicol. 116, 146-157 doi: 10.1111/bcpt.12295.
5. Carlsson, P., Hultin, H., and Tornwall, J. (1998). The early experiences of a national system for the identification and assessment of emerging health care technologies in Sweden. Int. J. Technol. Assess. Health Care 14, 687-694. doi: 10.1017/S0266462300012009.
6. Dental and Pharmaceutical Benefits Agency (2017). Dental and Pharmaceutical Benefits Agency. Available online at: www.tlv.se/In-English/in-english/ (Accessed June 1, 2017).
7. Ermisch, M., Bucsics, A., Vella Bonanno, P., Arickx, F., Bybau, A., Bochenek, T., et al. (2016). Payers' views of the changes arising through the possible adoption of adaptive pathways. Front. Pharmacol. 7:305. doi: 10.3389/fphar.2016.00305.
8. EuroScan (2017). The EuroScan International Network. Available online at: https://www.euroscan.org/ (Accessed June 1, 2017).
9. Godman, B., Malmstrom, R. E., Diogene, E., Gray, A., Jayathissa, S., Timoney, A., et al. (2015). Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev. Clin. Pharmacol. 8, 77-94. doi: 10.1586/17512433.2015.990380.
10. Godman, B., Wettermark, B., Hoffmann, M., Andersson, K., Haycox, A., and Gustafsson, L. L. (2009). Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev. Pharmacoecon. Outcomes Res. 9, 65-83. doi: 10.1586/14737167.9.1.65.
11. Gustafsson, L. L., Wettermark, B., Godman, B., Andersen-Karlsson, E., Bergman, U., Hasselstrom, J., et al. (2011). The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin. Pharmacol. Toxicol. 108, 224-233. doi: 10.1111/j.1742-7843.2011.00682.x.
12. Gustafsson, L. L., Wettermark, B., Kalin, M., Korkmaz, S., Persson, M. E., Almkvist, H., et al. (2008). A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment. Lakartidningen 105, 2917-2922. Available online at: http://www.lakartidningen.se/OldWebArticlePdf/1/10486/LKT0842s2917_2922.pdf.
13. HTA (2017a). The Health Technology Assessment (HTA) Glossary. Horizon Scanning. Available online at: http://htaglossary.net/HomePage (Accessed June 1, 2017).
14. HTA (2017b). The Health Technology Assessment (HTA) Glossary. Early Awareness and Alert System. Available online at: http://htaglossary.net/HomePage (Accessed June 1, 2017).
15. Janusinfo (2017). Janusinfo (The Website of the Drug and Therapeutic Committee and the Health and Medical Care Administration of the Stockholm County Council). Available online at: http://www.janusinfo.se/ (Accessed June 1, 2017).
16. Joppi, R., Dematte, L., Menti, A. M., Pase, D., Poggiani, C., and Mezzalira, L. (2009). The Italian horizon scanning project. Eur. J. Clin. Pharmacol. 65, 775-781. doi: 10.1007/s00228-009-0666-z.
17. Kardakis, T., Tomson, G., Wettermark, B., Brommels, M., Godman, B., and Bastholm-Rahmner, P. (2015). The establishment and expansion of an innovative centre for rational pharmacotherapy-determinants and challenges. Int. J. Health Plan. Manage. 30, 14-30. doi: 10.1002/hpm.2202.
18. Lepage-Nefkens, I., Douw, K., Mantjes, G., de Graaf, G., Leroy, R., and Cleemput, I. (2017). Horizon Scanning for Pharmaceuticals: Proposal for the BeNeLuxA Collaboration. Health Services Research (HSR). Brussel: Belgian Health Care Knowledge Centre (KCE). Report No.: D/2017/10.273/15.
19. Matusewicz, W., Godman, B., Pedersen, H. B., Furst, J., Gulbinovic, J., Mack, A., et al. (2015). Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe. Expert Rev. Pharmacoecon. Outcomes Res. 15, 755-758. doi: 10.1586/14737167.2015.1085803.
20. Medical Products Agency (2017). Medical Products Agency. The National Pharmaceutical Strategy 2017. Available online at: http://www.lakemedelsverket.se/overgripande/Om-Lakemedelsverket/Nationell-lakemedelsstrategi (Accessed June 1, 2017).
21. NHS (2017). The NHS Specialist Pharmacy Service. Available online at: https://www.sps.nhs.uk (Accessed June 1, 2017).
22. Packer, C., Gutierrez-Ibarluzea, I., and Simpson, S. (2012). The evolution of early awareness and alert methods and systems. Int. J. Technol. Assess. Health Care 28, 199-200. doi: 10.1017/S0266462312000426.
23. Packer, C., Simpson, S., and de Almeida, R. T. (2015). EuroScan international network member agencies: their structure, processes, and outputs. Int. J. Technol. Assess. Health Care 31, 78-85. doi: 10.1017/S0266462315000100.
24. Robert, G., Gabbay, J., and Stevens, A. (1998). Which are the best information sources for identifying emerging health care technologies? An international Delphi survey. Int. J. Technol. Assess. Health Care 14, 636-643. doi: 10.1017/S0266462300011946.
25. Scottish Medicines Consortium (2015). Scottish Medicines Consortium. Guidance on Horizon Scanning Process 2015. Available online at: https://www.scottishmedicines.org.uk/About_SMC/What_we_do/Horizon_Scanning/Guidance:on_Horizon_Scanning (Accessed June 1, 2017).
26. Simpson, S., Packer, C., Carlsson, P., Sanders, J. M., Ibarluzea, I. G., Fay, A. F., et al. (2008). Early identification and assessment of new and emerging health technologies: actions, progress, and the future direction of an international collaboration-EuroScan. Int. J. Technol. Assess. Health Care 24, 518-525. doi: 10.1017/S0266462308080689.
27. The Swedish Agency for HTA and Assessment of Social Services (2017). The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). Available online at: http://www.sbu.se/ (Accessed June 1, 2017).
28. The Swedish Association of Local Authorities and Regions (2017a). Managed Introduction - This is How it Works. Available online at: http://www.janusinfo.se/Managed-introduction-this-is-how-it-works/ (Accessed June 1, 2017).
29. The Swedish Association of Local Authorities and Regions (2017b). The Swedish Association of Local Authorities and Regions. Available online: https://skl.se/ (Accessed June 1, 2017).
30. The Swedish Association of Local Authorities and Regions (2017c). Managed Introduction - This Is How It Works/Horizon Scanning. Available online at: http://www.janusinfo.se/Managed-introduction-this-is-how-it-works/Horizon-scanning/ (Accessed June 1, 2017).
31. Wettermark, B., Godman, B., Andersson, K., Gustafsson, L. L., Haycox, A., and Bertele, V. (2008). Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe. Pharmacoeconomics 26, 537-550. doi: 10.2165/00019053-200826070-00001.
32. Wettermark, B., Godman, B., Eriksson, C., van Ganse, E., Garattini, S., Joppi, R., et al. (2010a). Einführung neuer Arzneimittel in europäische Gesundheitssysteme. G+G Wissenschaft 10, 24-34. Available online at: https://www.wido.de/fileadmin/wido/downloads/pdf_ggw/wido_ggw_aufs3_0710.pdf.
33. Wettermark, B., Persson, M. E., Wilking, N., Kalin, M., Korkmaz, S., Hjemdahl, P., et al. (2010b). Forecasting drug utilization and expenditure in a metropolitan health region. BMC Health Serv. Res. 10:128. doi: 10.1186/1472-6963-10-128.
34. WHO Regional Office for Europe (2015). Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research. Copenhagen: World Health Organization; Regional Office for Europe.